Development and testing of a tool to assess patient preferences for phase I clinical trial participation
- PMID: 25530552
- PMCID: PMC4474780
- DOI: 10.1002/pon.3731
Development and testing of a tool to assess patient preferences for phase I clinical trial participation
Keywords: End-Stage Cancer; Patient Preferences; Phase I Trials; Physician Recommendation; Reearch Ethics.
Conflict of interest statement
References
-
- Peppercorn JM, Smith TJ, Helft PR, Debono DJ, Berry SR, Wollins DS, et al. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29(6):755–760. Epub 2011/01/26. doi: JCO.2010.33.1744 [pii] 10.1200/JCO.2010.33.1744. PubMed PMID: 21263086. - PubMed
-
- Pieterse AH, Baas-Thijssen MC, Marijnen CA, Stiggelbout AM. Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer. 2008;99(6):875–882. Epub 2008/09/11. doi: 6604611 [pii] 10.1038/sj.bjc.6604611. PubMed PMID: 18781148. - PMC - PubMed
-
- Tomamichel M, Sessa C, Herzig S, de Jong J, Pagani O, Willems Y, et al. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients. Ann Oncol. 1995;6(4):363–369. Epub 1995/04/01. PubMed PMID: 7619751. - PubMed
-
- Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA. 2004;292(13):1593–1601. Epub 2004/10/07. doi: 292/13/1593 [pii] 10.1001/jama.292.13.1593. PubMed PMID: 15467062. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
